Variant report
Variant | nsv999663 |
---|---|
Chromosome Location | chr3:60478040-60521596 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:22)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:22 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:60483853..60486464-chr3:60489187..60492049,2 | K562 | blood: | |
2 | chr3:60488135..60490633-chr3:60491194..60494068,2 | K562 | blood: | |
3 | chr3:60475674..60478079-chr3:60479619..60482202,2 | K562 | blood: | |
4 | chr3:60503536..60506034-chr3:60508761..60510926,2 | K562 | blood: | |
5 | chr3:60492215..60494697-chr3:60503496..60505338,2 | K562 | blood: | |
6 | chr3:60488135..60490633-chr3:60491194..60494068,2 | K562 | blood: | |
7 | chr3:60483853..60486464-chr3:60489187..60492049,2 | K562 | blood: | |
8 | chr3:60503536..60506034-chr3:60508761..60510926,2 | K562 | blood: | |
9 | chr3:60476221..60479058-chr3:60482642..60484706,2 | K562 | blood: | |
10 | chr3:60502053..60505036-chr3:60509426..60512103,2 | K562 | blood: | |
11 | chr3:60476221..60479058-chr3:60482642..60484706,2 | K562 | blood: | |
12 | chr3:60263321..60265309-chr3:60503721..60505576,2 | K562 | blood: | |
13 | chr3:60486499..60489215-chr3:60499142..60502130,2 | K562 | blood: | |
14 | chr3:60509060..60510930-chr3:60511428..60512938,2 | K562 | blood: | |
15 | chr3:60492215..60494697-chr3:60503496..60505338,2 | K562 | blood: | |
16 | chr3:60509060..60510930-chr3:60511428..60512938,2 | K562 | blood: | |
17 | chr3:60500352..60502884-chr3:60536251..60537952,2 | K562 | blood: | |
18 | chr3:60506754..60508368-chr3:60516500..60519417,2 | K562 | blood: | |
19 | chr3:60475674..60478079-chr3:60479619..60482202,2 | K562 | blood: | |
20 | chr3:60486499..60489215-chr3:60499142..60502130,2 | K562 | blood: | |
21 | chr3:60506754..60508368-chr3:60516500..60519417,2 | K562 | blood: | |
22 | chr3:60502053..60505036-chr3:60509426..60512103,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FEZF2-9 | chr3:60521543-60522712 | NONHSAT090160 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573093202 | chr3:60483210-60483211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371241800 | chr3:60483268-60483269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79251359 | chr3:60483291-60483292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192678134 | chr3:60483292-60483293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116005988 | chr3:60483311-60483312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528678754 | chr3:60483325-60483326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199757535 | chr3:60483333-60483334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78456488 | chr3:60483338-60483339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6789802 | chr3:60483364-60483365 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs566810667 | chr3:60483382-60483383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113286561 | chr3:60483402-60483403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115126692 | chr3:60483443-60483444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150859951 | chr3:60483444-60483445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538921756 | chr3:60483461-60483462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557004847 | chr3:60483512-60483513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551245581 | chr3:60483532-60483533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575175602 | chr3:60483590-60483591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533682122 | chr3:60483609-60483610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11708700 | chr3:60483613-60483614 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs184763090 | chr3:60483636-60483637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539962701 | chr3:60483672-60483673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs28594929 | chr3:60483695-60483696 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs189146155 | chr3:60483725-60483726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544886666 | chr3:60483739-60483740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181517994 | chr3:60483758-60483759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145473551 | chr3:60483775-60483776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115782347 | chr3:60483784-60483785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140059532 | chr3:60483786-60483787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560495401 | chr3:60483815-60483816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144014841 | chr3:60483820-60483821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114743070 | chr3:60483830-60483831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147316624 | chr3:60483838-60483839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75793140 | chr3:60483876-60483877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73101807 | chr3:60483918-60483919 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs569018013 | chr3:60483919-60483920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79012902 | chr3:60483925-60483926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576959249 | chr3:60483969-60483970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554240580 | chr3:60483993-60483994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566147201 | chr3:60483996-60483997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141024524 | chr3:60484006-60484007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149864414 | chr3:60484055-60484056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144888587 | chr3:60484056-60484057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs72882138 | chr3:60484092-60484093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575002336 | chr3:60484094-60484095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556378154 | chr3:60484105-60484106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574373591 | chr3:60484119-60484120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142103948 | chr3:60484133-60484134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560485880 | chr3:60484137-60484138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527717412 | chr3:60484160-60484161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73101811 | chr3:60484167-60484168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Cancer | 18162546 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Mental retardation | 17847001 | CNVD |
Neuroticism | 17667963 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Cancer | 20164920 | CNVD |
Schizophrenia | 23813976 | CNVD |
Autism | 22102821 | CNVD |
Prostate cancer | 19363497 | CNVD |
Malaria | 21533027 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Colorectal cancer | 21518781 | CNVD |
Esophageal cancer | 21518781 | CNVD |
Cancer | 20164919 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:60483200-60484000 | Enhancers | Brain Germinal Matrix | brain |
2 | chr3:60483400-60483800 | Enhancers | Fetal Lung | lung |
3 | chr3:60483400-60485000 | Enhancers | Fetal Heart | heart |
4 | chr3:60483600-60484000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr3:60483600-60484000 | Enhancers | Duodenum Smooth Muscle | Duodenum |
6 | chr3:60483600-60484000 | Enhancers | Fetal Brain Female | brain |
7 | chr3:60490200-60491000 | Enhancers | Primary B cells from peripheral blood | blood |
8 | chr3:60499600-60500200 | ZNF genes & repeats | Adipose Nuclei | Adipose |
9 | chr3:60499800-60500200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
10 | chr3:60499800-60501000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
11 | chr3:60500000-60501000 | Enhancers | Fetal Muscle Trunk | muscle |
12 | chr3:60500200-60500600 | Weak transcription | Adipose Nuclei | Adipose |
13 | chr3:60500600-60500800 | Enhancers | Adipose Nuclei | Adipose |
14 | chr3:60500600-60500800 | Enhancers | Right Atrium | heart |
15 | chr3:60500600-60501000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr3:60500600-60501000 | Enhancers | Right Ventricle | heart |
17 | chr3:60500600-60501200 | Enhancers | Fetal Heart | heart |
18 | chr3:60500600-60501200 | Enhancers | K562 | blood |
19 | chr3:60500800-60501200 | Enhancers | Fetal Kidney | kidney |
20 | chr3:60500800-60501200 | Enhancers | Left Ventricle | heart |
21 | chr3:60500800-60501600 | Weak transcription | Right Atrium | heart |
22 | chr3:60507600-60508200 | Enhancers | Fetal Brain Male | brain |
23 | chr3:60509400-60523400 | Weak transcription | H9 Cell Line | embryonic stem cell |
24 | chr3:60514800-60519000 | Weak transcription | Fetal Kidney | kidney |
25 | chr3:60516200-60516400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
26 | chr3:60518200-60519000 | Enhancers | Fetal Brain Female | brain |
27 | chr3:60519000-60519200 | Enhancers | Fetal Kidney | kidney |
28 | chr3:60519200-60522200 | Weak transcription | Fetal Kidney | kidney |